Durvalumab supplementation for non-small-cell lung cancer: a meta-analysis study
Crossref DOI link: https://doi.org/10.1186/s13019-024-02940-3
Published Online: 2024-07-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wang, Chengchen
Fu, Hongyi
Wang, Feng
Text and Data Mining valid from 2024-07-04
Version of Record valid from 2024-07-04
Article History
Received: 21 August 2023
Accepted: 17 June 2024
First Online: 4 July 2024
Declarations
:
: Not applicable.
: The authors declare no competing interests.